glp-1 weight loss drug news november 2025 Poll: 1 in 8 Adults Say They Are Currently Taking a for Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Chart: 1 in 8 Americans

The price of GLP-1 drugs has attracted the scrutiny of lawmakers, and Novo Nordisk's chief executive Lars Fruergaard Jrgensen has agreed to appear at a Senate hearing next week to defend the pricing of the group's semaglutide-based therapies

Artificial Intelligence in Anti-Obesity Drug Discovery: Unlocking Next-Generation Therapeutics

[DOI] [PubMed] [Google Scholar] 392.Pyke C., Heller R.S., Kirk R.K., Orskov C., Reedtz-Runge S., Kaastrup P

As GLP-1 medications affect your metabolism, sugar level, and digestion, using them without a medical prescription is unsafe

[DOI] [PMC free article] [PubMed] [Google Scholar] [16].Meier JJ

H., Brown-Frandsen, K., et al